A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Dendritic cells are rare haematopoietic cells that reside in a number of organs and tissues. By capturing, processing and presenting antigens to T cells, dendritic cells are essential for immune surveillance and the regulation of specific immunity. Several members of the tumour necrosis factor receptor (TNFR) superfamily are integral to the regulation of the immune response. These structurally related proteins modulate cellular functions ranging from proliferation and differentiation to inflammation and cell survival or deaths. The functional activity of dendritic cells is greatly increased by signalling through the TNFR family member CD40. Here we report the characterization of RANK (for receptor activator of NF-kappaB), a new member of the TNFR family derived from dendritic cells, and the isolation of a RANK ligand (RANKL) by direct expression screening. RANKL augments the ability of dendritic cells to stimulate naive T-cell proliferation in a mixed lymphocyte reaction, and increases the survival of RANK+ T cells generated with interleukin-4 and transforming growth factor (TGF)-beta. Thus RANK and RANKL seem to be important regulators of interactions between T cells and dendritic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The receptor that mediates all known activities for RANKL is called receptor activator of nuclear factor B (RANK) (Figs. 1 and 2).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [41]
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,658
Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., & Alber, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.747 · Cited by 1,983
The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,887
Activation of human dendritic cells through CD40 cross-linking.
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., & Banchereau, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1263 · Cited by 1,317
TRAF2-Mediated Activation of NF-κB by TNF Receptor 2 and CD40
Rothe, M., Sarma, V., Dixit, V. M., & Goeddel, D. V. (1995) · Science · doi:10.1126/science.7544915 · Cited by 1,051
Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F. S., Frankel, W. N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25190 · Cited by 1,042
Molecular and biological characterization of a murine ligand for CD40
Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., et al. (1992) · Nature · doi:10.1038/357080a0 · Cited by 1,022
Self-citationHerpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
Cited by
Items 801–900 of 1,012
RANKL, a necessary chance for clinical application to osteoporosis and cancer-related bone diseases
Yasuda, H. (2013) · World Journal of Orthopedics · doi:10.5312/wjo.v4.i4.207 · Cited by 67
Advances in bone biology and new treatments for bone loss
Gallagher, J. C. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.04.005 · Cited by 67
Bone remodelling in inflammatory arthritis
Goldring, S. R., Purdue, P. E., Crotti, T. N., Shen, Z., Flannery, M. R., Binder, N. B., Ross, F. P., & McHugh, K. P. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202199 · Cited by 67
M cell targeting engineered biomaterials for effective vaccination
Islam, M. A., Firdous, J., Badruddoza, A. Z. M., Reesor, E., Azad, M. A., Hasan, A., Lim, M., Cao, W., Guillemette, S. R., & Cho, C. S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.041 · Cited by 67
Maruyama, T., Fukushima, H., Nakao, K., Shin, M., Yasuda, H., Weih, F., Doi, T., Aoki, K., Alles, N., Ohya, K., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091032 · Cited by 67
Inhibition of RANKL as a treatment for osteoporosis: Preclinical and early clinical studies
McClung, M. R. (2006) · Current Osteoporosis Reports · doi:10.1007/s11914-006-0012-7 · Cited by 67
RANK/RANKL/OPG Signaling in the Brain: A Systematic Review of the Literature
Glasnović, A., O’Mara, N., Kovačić, N., Grčević, D., & Gajović, S. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590480 · Cited by 66
Taams, L. S., van Eden, W., & Wauben, M. H. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199905)29:05<1543::aid-immu1543>3.0.co;2-r · Cited by 55
RANKL Induces Organized Lymph Node Growth by Stromal Cell Proliferation
Hess, E., Duhéron, V., Décossas, M., Lézot, F., Berdal, A., Chea, S., Golub, R., Bosisio, M. R., Bridal, S. L., Choi, Y., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101513 · Cited by 66
Teng, Y.-T. A. (2006) · Journal of Dental Research · doi:10.1177/154405910608500302 · Cited by 66
Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages
Fujimura, T., Kambayashi, Y., Furudate, S., Asano, M., Kakizaki, A., & Aiba, S. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.209 · Cited by 66
Lee, Z. H., Kwack, K., Kim, K. K., Lee, S. H., & Kim, H. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1536 · Cited by 66
Characterization of TNFRSF19, a Novel Member of the Tumor Necrosis Factor Receptor Superfamily
Hu, S., Tamada, K., Ni, J., Vincenz, C., & Chen, L. (1999) · Genomics · doi:10.1006/geno.1999.5979 · Cited by 66
Okada, Y., Morimoto, I., Ura, K., Watanabe, K., Eto, S., Kumegawa, M., Raisz, L. G., Pilbeam, C. C., & Tanaka, Y. (2002) · Endocrine Journal · doi:10.1507/endocrj.49.483 · Cited by 66
Makino, M., Wakamatsu, S.-I., Shimokubo, S., Arima, N., & Baba, M. (2000) · Virology · doi:10.1006/viro.2000.0445 · Cited by 66
Psychological stress and aging: role of glucocorticoids (GCs)
Hasan, K., Rahman, M. S., Arif, K. M. T., & Sobhani, M. E. (2011) · AGE · doi:10.1007/s11357-011-9319-0 · Cited by 65
Osteomimicry: How the Seed Grows in the Soil
Rucci, N., & Teti, A. M. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0365-1 · Cited by 65
Singh, N., Singh, S. M., & Shrivastava, P. (2005) · Immunopharmacology and Immunotoxicology · doi:10.1081/iph-51287 · Cited by 65
Dendritic Cell Precursors Are Permissive to Dengue Virus and Human Immunodeficiency Virus Infection
Kwan, W.-H., Helt, A.-M., Marañón, C., Barbaroux, J.-B., Hosmalin, A., Harris, E., Fridman, W. H., & Mueller, C. G. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7291-7299.2005 · Cited by 65
Samura, A., Wada, S., Suda, S., Iitaka, M., & Katayama, S. (2000) · Endocrinology · doi:10.1210/endo.141.10.7715 · Cited by 54
The dendritic cell in allergic airway diseases: a new player to the game
Lambrecht, B. N. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01061.x · Cited by 65
Maffia, P., Brewer, J. M., Gracie, J. A., Ianaro, A., Leung, B. P. L., Mitchell, P. J., Smith, K. M., McInnes, I. B., & Garside, P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.151 · Cited by 65
Editorial: Cell Number Versus Cell Vigor--What Really Matters to a Regenerating Skeleton?
Manolagas, S. C. (1999) · Endocrinology · doi:10.1210/endo.140.10.7129 · Cited by 65
Nakagawa, N., Yasuda, H., Yano, K., Mochizuki, S.-I., Kobayashi, N., Fujimoto, H., Shima, N., Morinaga, T., Chikazu, D., Kawaguchi, H., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1601 · Cited by 64
Regulation of T cell-associated tissues and T cell activation by RANKL-RANK-OPG
Walsh, M. C., & Choi, Y. (2021) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01178-y · Cited by 64
Role of the RANK/RANKL pathway in breast cancer
Kiesel, L., & Kohl, A. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.01.001 · Cited by 64
Titanji, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01851 · Cited by 64
Self-Assembled RANK Induces Osteoclastogenesis Ligand-Independently
Kanazawa, K., & Kudo, A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050706 · Cited by 54
Sakai, N., Sweringen, H. L. V., Schuster, R. M., Blanchard, J. A., Burns, J. M., Tevar, A. D., Edwards, M. J., & Lentsch, A. B. (2011) · Hepatology · doi:10.1002/hep.24756 · Cited by 64
Izawa, A., Ishihara, Y., Mizutani, H., Kobayashi, S., Goto, H., Okabe, E., Takeda, H., Ozawa, Y., Kamiya, Y., Sugita, Y., et al. (2014) · Infection and Immunity · doi:10.1128/iai.01618-13 · Cited by 64
Is there a common mechanism of gastrointestinal nematode expulsion?
Lawrence, C. E. (2003) · Parasite Immunology · doi:10.1046/j.1365-3024.2003.00630.x · Cited by 64
Tat, S. K., Padrines, M., Theoleyre, S., Couillaud-Battaglia, S., Heymann, D., Redini, F., & Fortun, Y. (2006) · Bone · doi:10.1016/j.bone.2006.03.016 · Cited by 63
“Indeed, in most of the cytokine–cytokine receptor systems, like the other TNF/TNFR family members, the cytokine interacts with its transmembranous receptor which, like RANK, possesses a long C-terminal cytoplasmic domain [36] responsible for intracellular signal transductions [37,38].”
BackgroundStolina, M., Dwyer, D., Ominsky, M. S., Corbin, T., Van, G., Bolon, B., Sarosi, I., McCabe, J., Zack, D. J., & Kostenuik, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7497 · Cited by 63
Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL
BORD, S., FRITH, E., IRELAND, D., SCOTT, M., CRAIG, J., & COMPSTON, J. (2005) · Bone · doi:10.1016/j.bone.2004.12.006 · Cited by 63
RANKL/RANK – From bone physiology to breast cancer
Sigl, V., & Penninger, J. M. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.01.002 · Cited by 63
Tumor–host cell interactions in the bone disease of myeloma
Fowler, J. A., Edwards, C. M., & Croucher, P. I. (2010) · Bone · doi:10.1016/j.bone.2010.06.029 · Cited by 63
Yamada, Y., Ando, F., Niino, N., & Shimokata, H. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00125-2 · Cited by 63
Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis
Jules, J., Ashley, J. W., & Feng, X. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.511179 · Cited by 63
RANK as a therapeutic target in cancer
González‐Suárez, E., & Sanz‐Moreno, A. (2016) · FEBS Journal · doi:10.1111/febs.13645 · Cited by 63
A T Cell View of the Bone Marrow
Bonomo, A. C., Monteiro, A. C., Gonçalves-Silva, T., Cordeiro-Spinetti, E., Galvani, R. G. A., & Balduíno, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00184 · Cited by 63
Watanabe, K., Tominari, T., Hirata, M., Matsumoto, C., Hirata, J., Murphy, G., Nagase, H., Miyaura, C., & Inada, M. (2017) · FEBS Open Bio · doi:10.1002/2211-5463.12258 · Cited by 63
Xing, L., Carlson, L., Story, B., Tai, Z., Keng, P., Siebenlist, U., & Boyce, B. F. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.2.260 · Cited by 57
Downstream Regulator TANK Binds to the CD40 Recognition Site on TRAF3
Li, C., Ni, C., Havert, M. L., Cabezas, E., He, J., Kaiser, D., Reed, J. C., Satterthwait, A. C., Cheng, G., & Ely, K. R. (2002) · Structure · doi:10.1016/s0969-2126(02)00733-5 · Cited by 63
Kamijo, S., Nakajima, A., Ikeda, K., Aoki, K., Ohya, K., Akiba, H., Yagita∥, H., & Okumura, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.098 · Cited by 63
Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis
Bolon, B. N., Shalhoub, V., Kostenuik, P. J., Campagnuolo, G., Morony, S., Boyle, W. J., Zack, D. J., & Feige, U. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10680 · Cited by 63
Yu, Q., Gu, J., Kovacs, C. M., Freedman, J. J., Thomas, E. K., & Ostrowski, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1797 · Cited by 63
TRANCE–RANK, a New Signal Pathway Involved in Lymphocyte Development and T Cell Activation
Allison Green, E., & Flavell, R. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1017 · Cited by 59
AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progression
Cirelli, J. A., Park, C. H., MacKool, K., Taba, M., Lustig, K., Burstein, H., & Giannobile, W. V. (2008) · Gene Therapy · doi:10.1038/gt.2008.174 · Cited by 62
Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis
Bajpai, M., Chopra, P., Dastidar, S. G., & Ray, A. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.5.641 · Cited by 62
Al-Barghouthi, B. M., Mesner, L. D., Calabrese, G. M., Brooks, D. J., Tommasini, S. M., Bouxsein, M., Horowitz, M. C., Rosen, C. J., Nguyen, K. K., Haddox, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23649-0 · Cited by 62
Wiethe, C., Dittmar, K., Doan, T., Lindenmaier, W., & Tindle, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4121 · Cited by 54
Bone Resorption in Chronic Otitis media: The Role of the Osteoclast
Jung, J. Y., & Chole, R. A. (2002) · ORL · doi:10.1159/000057787 · Cited by 62
Chirmule, N. B., Raper, S. E., Burkly, L. C., Thomas, D. W., Tazelaar, J., Hughes, J. V., & Wilson, J. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3345-3352.2000 · Cited by 62
Osteoclast formation and bone resorption are inhibited by megakaryocytes
Beeton, C. A., Bord, S., Ireland, D., & Compston, J. E. (2006) · Bone · doi:10.1016/j.bone.2006.06.004 · Cited by 61
“OPG, a member of the TNF receptor (TNF-R) super-family [7,8], acts as a decoy receptor by blocking the interaction of RANKL with its functional receptor RANK [9], thereby inhibiting osteoclastogenesis.”
BackgroundThe osteoimmunology of alveolar bone loss
Tompkins, K. A. (2016) · Connective Tissue Research · doi:10.3109/03008207.2016.1140152 · Cited by 61
Multiple Myeloma and Bone: The Fatal Interaction
Marino, S., & Roodman, G. D. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031286 · Cited by 55
Debard, N., Sierro, F., & Kraehenbühl, J.-P. (1999) · Seminars in Immunology · doi:10.1006/smim.1999.0174 · Cited by 61
.BETA.-Cryptoxanthin and Bone Metabolism: The Preventive Role in Osteoporosis
Yamaguchi, M. (2008) · Eisei kagaku · doi:10.1248/jhs.54.356 · Cited by 61
Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X L
Lundqvist, A., Nagata, T., & Kies, R. (2002) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0265-7 · Cited by 61
Mundy, G. R., Oyajobi, B. O., Gutierrez, G. E., Sterling, J. A. R., Padalecki, S. S., Elefteriou, F., & Zhao, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50020-3 · Cited by 61
Yoneda, T., Ishimaru, N., Arakaki, R., Kobayashi, M., Izawa, T., Moriyama, K., & Hayashi, Y. (2004) · Endocrinology · doi:10.1210/en.2003-1536 · Cited by 60
How zoledronic acid improves osteoporosis by acting on osteoclasts
Wang, B., Zhan, Y., Yan, L. W., & Hao, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.961941 · Cited by 60
Wagner, D., & Fahrleitner‐Pammer, A. (2010) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-010-0818-x · Cited by 60
Local Delivery of Recombinant Osteoprotegerin Enhances Postorthodontic Tooth Stability
Hudson, J. B., Hatch, N. E., Hayami, T., Shin, J. M., Stolina, M., Kostenuik, P. J., & Kapila, S. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9579-4 · Cited by 60
Osteoimmunology in orthodontic tooth movement
Jiang, C., Li, Z., Quan, H., Li, X., Zhao, J., Jiang, C., Wang, Y., Liu, J., Gou, Y., An, S., et al. (2014) · Oral Diseases · doi:10.1111/odi.12273 · Cited by 60
Bavachalcone inhibits osteoclast differentiation through suppression of NFATc1 induction by RANKL
Park, C. K., Lee, Y., Chang, E., Lee, M. H., Yoon, J. H., Ryu, J., & Kim, H. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.03.007 · Cited by 60
Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans
Vik, A., Mathiesen, E. B., Notø, A. W., Sveinbjørnsson, B., Brox, J. H., & Hansen, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.002 · Cited by 60
Immunolocalization of Receptor Activator of NF Kappa B Ligand in Rat Periapical Lesions
Zhang, X., & PENG, B. (2005) · Journal of Endodontics · doi:10.1097/01.don.0000153839.74546.66 · Cited by 60
Osteoclast lineage commitment of bone marrow precursors through expression of membrane-bound TRANCE
Lean, J. M., Matsuo, K., Fox, S. W., Fuller, K., Gibson, F. M., Draycott, G. S., Wani, M. R., Bayley, K. E., Wong, B. R., Choi, Y., et al. (2000) · Bone · doi:10.1016/s8756-3282(00)00306-9 · Cited by 60
Bone markers in multiple myeloma
Heider, U., Fleissner, C., Zavrski, I., Kaiser, M., Hecht, M., Jakob, C., & Sezer, O. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.034 · Cited by 60
RANKL/RANK/OPG: Key Therapeutic Target in Bone Oncology
Ando, K., Mori, K., Rédiní, F., & Heymann, D. (2008) · Current Drug Discovery Technologies · doi:10.2174/157016308785739857 · Cited by 60
Oestrogen action on bone cells.
Krassas, G. E., & Papadopoulou, P. (2001) · PubMed · Cited by 60
RANK and RANK ligand expression in primary human osteosarcoma
Branstetter, D. G., Rohrbach, K., Huang, L., Soriano, R., Tometsko, M. E., Blake, M., Jacob, A. P., & Dougall, W. C. (2015) · Journal of bone oncology · doi:10.1016/j.jbo.2015.06.002 · Cited by 59
Self-citationRANKL/RANK as Key Factors for Osteoclast Development and Bone Loss in Arthropathies
Leibbrandt, A., & Penninger, J. M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0298-6_7 · Cited by 59
Lin, X., Han, X., Kawai, T., & Taubman, M. A. (2010) · Infection and Immunity · doi:10.1128/iai.00944-10 · Cited by 59
Tominari, T., Matsumoto, C., Watanabe, K., Hirata, M., Grundler, F. M. W., Miyaura, C., & Inada, M. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.06.003 · Cited by 59
Okada, Y., Montero, A., Zhang, X., Sobue, T., Lorenzo, J. A., Doetschman, T., Coffin, J. D., & Hurley, M. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302113200 · Cited by 59
Spohn, G., Schwarz, K., Maurer, P., Illges, H., Rajasekaran, N., Choi, Y., Jennings, G. T., & Bachmann, M. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6211 · Cited by 58
“Osteoclastogenesis is initiated by the interaction of TNF-related activation-induced cytokine (TRANCE)(3)/receptor activator of NF- B ligand (RANKL) (3, 4) expressed on stromal cells and RANK (4) on the surface of osteoclast precursors.”
BackgroundBone-derived factors mediate crosstalk between skeletal and extra-skeletal organs
He, T., Qin, L., Chen, S., Huo, S., Li, J., Zhang, F., Yi, W., Mei, Y., & Xiao, G. (2025) · Bone Research · doi:10.1038/s41413-025-00424-1 · Cited by 58
“72 This research group also isolated RANKL as a RANK ligand by direct expression screening in the dendritic cells, which stimulates naive T-cell proliferation and survival by interacting with RANK in T cells.”
Osteoimmunology in Periodontitis: Local Proteins and Compounds to Alleviate Periodontitis
Sirisereephap, K., Maekawa, T., Tamura, H., Hiyoshi, T., Domon, H., Isono, T., Terao, Y., Maeda, T., & Tabeta, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105540 · Cited by 58
Soy Isoflavones and Bone Health: Focus on the RANKL/RANK/OPG Pathway
Hooshiar, S. H., Tobeiha, M., & Jafarnejad, S. (2022) · BioMed Research International · doi:10.1155/2022/8862278 · Cited by 58
Angela, Y., Haferkamp, S., Weishaupt, C., Ugurel, S., Becker, J. C., Oberndörfer, F., Alar, V., Satzger, I., & Gutzmer, R. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02353-5 · Cited by 58
Mun, S. H., Won, H. Y., Hernández, P., Aguila, H. L., & Lee, S. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1787 · Cited by 59
RANK ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse
Mori, H., Kitazawa, R., Mizuki, S., Nose, M., Maeda, S., & Kitazawa, S. (2002) · Histochemistry and Cell Biology · doi:10.1007/s00418-001-0376-9 · Cited by 58
Hormonal Regulation of Osteoclast Function
Martin, T. J., & Udagawa, N. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00005-8 · Cited by 58
Signal Transduction Pathways That Regulate the Fate of B Lymphocytes
Craxton, A., Otipoby, K. L., Jiang, A., & Clark, E. A. (1999) · Advances in immunology · doi:10.1016/s0065-2776(08)60786-5 · Cited by 58
The RANKL/RANK system as a therapeutic target for bone invasion by oral squamous cell carcinoma
Jimi, E., Shin, M., FURUTA, H., Tada, Y., & Kusukawa, J. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1794 · Cited by 57
Liu, W. X., Xu, D., Yang, H., Xu, H., Shi, Z., Cao, X., Takeshita, S., Liu, J., Teale, M., & Feng, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404687200 · Cited by 58
Jimi, E., & Katagiri, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147995 · Cited by 57
Lopez-Granados, E., Temmerman, S. T., Wu, L., Reynolds, J. C., Follmann, D., Liu, S., Nelson, D. L., Rauch, F., & Jain, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605715104 · Cited by 54
Wu, S., Kawahara, Y., Manabe, T., Ogawa, K., Matsumoto, M., Sasaki, A., & Yuge, L. (2009) · Pathobiology · doi:10.1159/000209387 · Cited by 57
Montecucco, F., Steffens, S., & Mach, F. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/75805 · Cited by 57
Hamilton, S. E., Tvinnereim, A., & Harty, J. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5603 · Cited by 57
Cbfa1 does not regulate RANKL gene activity in stromal/osteoblastic cells
O’Brien, C. A., Kern, B., Gubrij, I. B., Karsenty, G., & Manolagas, S. C. (2002) · Bone · doi:10.1016/s8756-3282(01)00692-5 · Cited by 57
Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen
Bord, S., Frith, E., Ireland, D. C., Scott, M. A., Craig, J. I. O., & Compston, J. E. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05024.x · Cited by 56
“OPG, a member of the TNF receptor (TNF-R) super-family (Simonet et al, 1997; Tsuda et al, 1997), acts as a decoy receptor by blocking the interaction of RANKL with its functional receptor RANK (Anderson et al, 1997), thereby inhibiting osteoclastogenesis.”
BackgroundOsteoimmunology and Bone Homeostasis: Relevance to Spondyloarthritis
Goldring, S. R. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0342-2 · Cited by 56
Honma, M., Ikebuchi, Y., & Suzuki, H. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107682 · Cited by 56
Buckley, K. A., & Fraser, W. D. (2002) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456320203900602 · Cited by 56
Gardella, T. J., Jüppner, H., Brown, E. M., Kronenberg, H. M., & Potts, J. T. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00056-3 · Cited by 56
Vitamin A differentially regulates RANKL and OPG expression in human osteoblasts
Jacobson, A., Johansson, S., Branting, M., & Melhus, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.092 · Cited by 55
Metadata
- Authors
- Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L.
- Corresponding author
- Anderson, Dirk M.
- Venue
- Nature
- Published
- 1997-11
- Volume
- 390
- Issue
- 6656
- Pages
- 175-179
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1650001464
- Cited by
- 2,290
- References
- 30
- Citations by year
- 2026: 31 · 2025: 32 · 2024: 37 · 2023: 45 · 2022: 53 · 2021: 79 · 2020: 74 · 2019: 63 · 2018: 56 · 2017: 71 · 2016: 53 · 2015: 73 · 2014: 80 · 2013: 83 · 2012: 94
- FWCI
- 37.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- RANK, RANK ligand, TNF receptor superfamily, dendritic cells, T cell proliferation, T cell survival, antigen presentation, immune regulation, IL-4, TGF-beta, mixed lymphocyte reaction
- MeSH terms
- Amino Acid Sequence, Animals, Carrier Proteins, Cell Line, Cells, Cultured, Chromosome Mapping, Chromosomes, Human, Pair 13, Chromosomes, Human, Pair 18, Dendritic Cells, Humans, Ligands, Membrane Glycoproteins, Membrane Proteins, Molecular Sequence Data, T-Lymphocytes, Transfection, Sequence Homology, Amino Acid, Receptors, Tumor Necrosis Factor, CD40 Ligand, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.